Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSH40 versus normal saline for perioperative neurocognitive disorders in shoulder arthroscopy
ChiCTR1900026996Phase 4Recruiting
- Sponsor
- Third Hospital of Hebei Medical University
- Start
- Nov 2019
- Modality
- Small Molecules, Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydroxyethyl starch + sodium chloride and Normal Saline-Benha University in perioperative neurocognitive disorder (2 arms), sponsored by Third Hospital of Hebei Medical University. Primary endpoint: Tumor necrosis factor alpha. Started Nov 2019; status: recruiting.
02
Drugs
hydroxyethyl starch + sodium chlorideNormal Saline-Benha University
03
Conditions
perioperative neurocognitive disorder
Beyond the preview
Go deeper on ChiCTR1900026996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026996.